Express Pharma January 16-31, 2020
India's Foremost Pharma & Biotech Magazine ~ Rare Diseases: Awaiting Renewed Focus
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
National Packaging Conference on recycling and sustainability of packaging materials held in…
The Packaging industry in India is anticipated to reach US $ 73.6 billion by 2020. It is predicted to grow at the rate 18 per cent…
DKSH opens new master distribution center to boost its Performance Materials business in India
The new facility, which further enhances DKSH’s already robust distribution network in India, will reinforce the company’s…
DSG Consumer Partners Leads Pre-Series A Funding in Power Gummies
The company will develop and launch a portfolio of vitamins and nutritional supplements in gummy format, without the use of…
Alembic gets US FDA nod for Tizanidine hydrochloride capsules used to treat spasticity
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Zanaflex Capsules, 2 mg, 4 mg, and 6…
Sun Pharma and Rockwell enter into licensing agreement for Triferic in India
Triferic is an innovative anaemia therapy for the patients who are undergoing haemodialysis and offers a unique treatment option
Roche aims to ‘underwhelm’ on SMA drug price to challenge rivals
Spinraza's list price is $750,000 in the first year, and $375,000 thereafter, while Novartis's gene therapy for the genetic muscle…
Sree Chitra develops Circumin fibrin wafer to target malignant cancer cells
The bio material wafer is targeted for implantation to the affected site after surgical removal of cancer tissue for killing any…
Will Budget 2020 be a salve or a sting for India Pharma Inc?
Will the sector get their shocks post-budget, via a revamped UCPMP, further pricing woes, etc?
Acasti Pharma’s krill oil-derived drug fails late-stage study
The Canada-based drug developer said CaPre failed to show a statistically significant reduction in blood triglycerides compared to…